• NMDA: Practical Excitotoxicity Assay Workflows

  2026-08-07

  Build reproducible excitotoxicity, calcium influx, and oxidative stress experiments with NMDA while preserving a clear link between receptor activation and downstream cell-death phenotypes. A practical workflow also shows how the NMDA glaucoma model can be paired with BMP4-GPX4 readouts to study retinal ganglion cell injury and protection.

• Rottlerin: Strategic Utility of a PKC Inhibitor in Translati

  2026-08-07

  This article offers a thought-leadership perspective on Rottlerin, a selective PKC inhibitor, bridging mechanistic insight with practical strategy for translational researchers. By integrating rigorous evidence and workflow guidance, we highlight how Rottlerin (SKU B6803, APExBIO) serves as a precision tool for dissecting cell proliferation, apoptosis, and endothelial barrier function—key factors in oncology and beyond.

• Tetrandrine Alkaloid: Strategic Ion Channel Modulation in Tr

  2026-08-06

  Explore the mechanistic depth and translational potential of Tetrandrine alkaloid as a DMSO-soluble, high-purity tool for ion channel modulation, inflammation, and cancer biology. This thought-leadership article fuses protocol insights, competitive benchmarking, and a vision for next-generation translational research.

• Temozolomide: Applied Workflows in DNA Repair and Glioma Mod

  2026-08-06

  Temozolomide is the small-molecule alkylating agent of choice for dissecting DNA repair mechanisms and modeling chemotherapy resistance, particularly in advanced glioma research. This article delivers hands-on workflow enhancements, troubleshooting strategies, and actionable protocol parameters to maximize experimental reproducibility and interpretability.

• Targeting Cdc42 to Mitigate Kidney Fibrosis: Mechanistic Ins

  2026-08-05

  A recent study identifies the small GTPase Cdc42 as a central mediator of kidney fibrosis and demonstrates that daphnepedunin A, a natural diterpenoid, can suppress fibrotic progression by modulating Cdc42-driven GSK-3β/β-catenin signaling. These findings provide a mechanistic rationale for selective Cdc42 inhibition as a therapeutic strategy in chronic kidney disease.

• WSP-5: Advanced Probe for Live-Cell Hydrogen Sulfide Detecti

  2026-08-05

  WSP-5 (Washington State Probe-5) enables highly sensitive, real-time detection of hydrogen sulfide (H2S) in live cells via a fast, selective fluorogenic mechanism. This article details its mechanism, validated benchmarks, and best-practice application parameters for disease-relevant research.

• Modulating Ionizable Lipids for Organ-Selective mRNA Deliver

  2026-08-04

  This study presents a multidimensional chemical approach to rapidly generate and optimize ionizable lipids (ILs) for lipid nanoparticle (LNP)–mediated, organ-selective mRNA delivery. The findings establish structure–function links that enable targeted mRNA transfection and have direct implications for improving the specificity and efficacy of mRNA therapeutics.

• Programmable 3D Gold Nanocluster Arrays via Polymer Pen Lith

  2026-08-04

  This study introduces a scalable, precisely tunable approach for fabricating highly ordered three-dimensional gold nanocluster arrays using polymer pen lithography (PPL). The resulting SERS substrates achieve exceptional sensitivity and reproducibility, advancing the practical deployment of SERS in biosensing and analytical applications.

• LAMP1 Modulates CXCL10-CXCR3 Axis in Macrophage Polarization

  2026-08-03

  This study elucidates how LAMP1 controls the CXCL10-CXCR3 axis, mediating macrophage polarization in both inflammatory and non-inflammatory contexts. The findings reveal context-dependent roles for CXCR3 signaling in regulating autophagy and macrophage phenotype, informing new strategies for inflammation research.

• Metformin Hydrochloride: Mechanistic Insights Beyond Diabete

  2026-08-03

  Explore the multifaceted scientific mechanisms of Metformin Hydrochloride (Metformin HCl), including AMPK signaling and Wnt/β-catenin modulation. This article delivers advanced perspectives for metabolic, musculoskeletal, and stem cell research applications.

• Phosphatase Inhibitor Cocktail 1 (100X in DMSO): Workflow Gu

  2026-08-02

  Phosphatase Inhibitor Cocktail 1 (100X in DMSO) is designed to prevent protein dephosphorylation during sample processing, making it essential for accurate phosphoproteomic and signaling pathway studies. It is not intended for diagnostic or therapeutic use, and is best applied in workflows where preservation of endogenous phosphorylation is critical.

• Tivozanib (AV-951): Redefining VEGFR Inhibition in Translati

  2026-08-01

  Explore how Tivozanib (AV-951) is reshaping anti-angiogenic therapy and translational oncology through mechanistic precision, advanced in vitro methodologies, and strategic guidance. This article offers in-depth insights into optimizing experimental design, benchmarking clinical outcomes, and envisioning the next frontiers in renal cell carcinoma treatment and beyond.

• PDK4-IN-1 Hydrochloride: Driving Translational Mitochondrial

  2026-07-31

  A strategic exploration of PDK4-IN-1 hydrochloride’s mechanistic and translational leverage, bridging mitochondrial metabolism research with actionable guidance for metabolic, cardiac, and oncology investigators. The article integrates new insights from recent medicinal chemistry advances, highlights protocol best practices, and offers a vision for next-generation metabolic modulation.

• Ganetespib (STA-9090): Disrupting Hsp90 for Translational On

  2026-07-31

  This thought-leadership article explores how Ganetespib (STA-9090), a next-generation triazolone-containing Hsp90 inhibitor from APExBIO, enables translational researchers to interrogate and disrupt oncogenic signaling networks. It integrates mechanistic insights into Hsp90 chaperone function, client protein dependencies, and emerging intersections with programmed cell death and unconventional protein secretion. By critically appraising recent findings and offering strategic guidance, the article charts a roadmap for leveraging Ganetespib in advanced cancer research, going beyond standard product narratives.

• Belinostat (PXD101): Optimizing HDAC Inhibition in Cancer As

  2026-07-30

  Belinostat (PXD101) delivers precise pan-HDAC inhibition and robust epigenetic modulation, empowering cancer researchers to dissect proliferation suppression and cell death in tumor models. This guide translates recent methodological advances into stepwise workflows, troubleshooting strategies, and real-world protocol enhancements for maximum research impact.

442 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page